Just.: Evotec acquires U.S-based Just Biotherapeutics for 73.59 million

In an announcement on Thursday, Evotec (ETR: EVT) said that it has acquired the U.S-based biologics company Just Biotherapeutics. The U.S. company is financially backed by the Gates Foundation. As per the sources, Evotec is investing £73.59 million on the acquisition to boost its presence in the biologics industry. Learn more about return on assets (ROA). The news comes only weeks after Evotec released its quarterly financial results that posted robust performance in its primary business in the first quarter. The company also released its full-year financial guidance that accounted for an economic blow from COVID-19 that has so farThe post Evotec acquires U.S-based Just Biotherapeutics for £73.59 million appeared first on Invezz.